Non-exposed bisphosphonate-related osteonecrosis of the jaw: a critical assessment of current definition, staging, and treatment guidelines. [electronic resource]
Producer: 20131017Description: 625-32 p. digitalISSN:- 1601-0825
- Angiogenesis Inhibitors -- adverse effects
- Anti-Bacterial Agents -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Bevacizumab
- Bisphosphonate-Associated Osteonecrosis of the Jaw -- pathology
- Denosumab
- Humans
- Jaw Diseases -- chemically induced
- Osteonecrosis -- chemically induced
- Practice Guidelines as Topic
- Terminology as Topic
No physical items for this record
Publication Type: Evaluation Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.